Market research
UNICHEMLAB.NSE Unichem Laboratories Limited
NSE INR Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 34B
- P/E ratio
- 11.17
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- -0.03
Profile
Instrument facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- INE351A01035
- Market cap
- 34B
- P/E ratio
- 11.17
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- -0.03
About
About Unichem Laboratories Limited
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in Asia, Europe, Africa, CIS, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, formulations, bulk drugs, and chemicals. It serves distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited.
Research context
Unichem Laboratories Limited appears in PyInvesting’s India Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- INR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the UNICHEMLAB.NSE discussion.
5 years, 6 months ago
Unichem Laboratories Limited is currently in a long term uptrend where the price is trading 10.9% above its 200 day moving average.
From a valuation standpoint, the stock is 64.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Unichem Laboratories Limited's total revenue rose by 9.8% to $3B since the same quarter in the previous year.
Its net income has increased by 261.4% to $236M since the same quarter in the previous year.
Finally, its free cash flow fell by 21.9% to $-353M since the same quarter in the previous year.
Based on the above factors, Unichem Laboratories Limited gets an overall score of 4/5.